Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Allergan Plc (AGN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 59,744,668
  • Shares Outstanding, K 332,580
  • Annual Sales, $ 14,571 M
  • Annual Income, $ 14,973 M
  • 36-Month Beta 1.11
  • Price/Sales 3.98
  • Price/Cash Flow 5.52
  • Price/Book 0.91

Price Performance

See More
Period Period Low Period High Performance
1-Month
163.17 +11.13%
on 12/28/17
181.97 -0.35%
on 01/19/18
+11.76 (+6.94%)
since 12/19/17
3-Month
160.07 +13.28%
on 12/05/17
192.01 -5.56%
on 10/20/17
-7.94 (-4.20%)
since 10/19/17
52-Week
160.07 +13.28%
on 12/05/17
256.80 -29.39%
on 07/25/17
-33.25 (-15.50%)
since 01/19/17

Most Recent Stories

More News
Amgen/Allergan's Avastin Biosimilar Secures EU Approval

Amgen (AMGN) and Allergan's Mvasi - a biosimilar version of Roche's cancer drug, Avastin - gets marketing approval in the EU.

AGN : 181.33 (+0.94%)
ABBV : 104.64 (+0.80%)
RHHBY : 30.6900 (+0.59%)
AMGN : 189.28 (+0.90%)
Cancer Space Update: Label Expansions, Data Readouts in Focus

This week the cancer space was abuzz with news of label expansion of Kyprolis, Lynparza and Kymriah and positive data readouts for Cabometyx and Keytruda.

AZN : 35.44 (+1.06%)
MRK : 61.28 (+0.25%)
AGN : 181.33 (+0.94%)
NVS : 86.94 (+0.61%)
EXEL : 28.00 (+0.50%)
RHHBY : 30.6900 (+0.59%)
AMGN : 189.28 (+0.90%)
BLRX : 1.09 (-1.80%)
European Commission Approves Amgen And Allergan's MVASI® (Biosimilar Bevacizumab) For The Treatment Of Certain Types Of Cancer

Amgen (NASDAQ: AMGN) and Allergan plc. (NYSE: AGN) today announced that the European Commission (EC) has granted marketing authorization for MVASI® (biosimilar bevacizumab). MVASI is the first biosimilar...

AGN : 181.33 (+0.94%)
AMGN : 189.28 (+0.90%)
Teva's Trisenox Gets FDA Approval as First-Line Treatment

Teva Pharmaceutical (TEVA) receives approval from the FDA for label expansion of its leukemia drug, Trisenox, in first-line setting.

MYL : 46.73 (+0.47%)
NVO : 57.79 (+2.27%)
AGN : 181.33 (+0.94%)
TEVA : 20.70 (-0.05%)
Will Amgen (AMGN) Continue to Tread Growth Path This Year?

Amgen (AMGN) stock outperformed the industry in 2017. We will have to wait and see if it can keep the momentum alive in 2018.

AGN : 181.33 (+0.94%)
RHHBY : 30.6900 (+0.59%)
AMGN : 189.28 (+0.90%)
PFE : 36.94 (-0.14%)
Ironwood and Allergan Announce Settlement with Sun Pharma Resolving LINZESS(R) (linaclotide) Patent Litigation

Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD) and Allergan plc (NYSE: AGN) announced today that the companies have reached an agreement with wholly-owned subsidiaries of Sun Pharmaceutical...

IRWD : 15.38 (+2.53%)
AGN : 181.33 (+0.94%)
1st trial date set in state lawsuit over opioid epidemic

OKLAHOMA CITY (AP) — The first trial date has been set for a lawsuit by a state against pharmaceutical companies over the opioid epidemic, according to Oklahoma's attorney general.

AGN : 181.33 (+0.94%)
Big Pharma CEOs Speak About Impact of Tax Reform on M&A

This week, senior executives of some large drug companies discussed the impact of tax reform on mergers and acquisition and their plans to use the excess cash at the JP Morgan HealthCare conference.

CELG : 102.65 (+0.91%)
JNJ : 147.36 (+0.30%)
MRK : 61.28 (+0.25%)
LLY : 85.49 (-0.38%)
AGN : 181.33 (+0.94%)
GILD : 80.98 (-0.23%)
BIIB : 342.41 (-0.59%)
Judge urges action on '100 percent manmade' opioid crisis

COLUMBUS, Ohio (AP) — A federal judge on Tuesday set a goal of doing something about the nation's opioid epidemic this year, while noting the drug crisis is "100 percent man-made."

ABC : 100.06 (-0.79%)
MCK : 170.36 (-0.83%)
JNJ : 147.36 (+0.30%)
AGN : 181.33 (+0.94%)
CAH : 71.91 (+0.28%)
3 Native American tribes sue opioid industry groups

SIOUX FALLS, S.D. (AP) — Three Native American tribes in the Dakotas are suing opioid manufacturers and distributors, alleging they concealed and minimized the addiction risk of prescription drugs.

ABC : 100.06 (-0.79%)
MCK : 170.36 (-0.83%)
AGN : 181.33 (+0.94%)
CAH : 71.91 (+0.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators are in flux.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More

Business Summary

Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan...

See More

Key Turning Points

2nd Resistance Point 183.66
1st Resistance Point 182.49
Last Price 181.33
1st Support Level 179.64
2nd Support Level 177.96

See More

52-Week High 256.80
Fibonacci 61.8% 219.85
Fibonacci 50% 208.43
Fibonacci 38.2% 197.02
Last Price 181.33
52-Week Low 160.07

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.